Pan Hao

Prof. Dr. Pan Hao

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
LSLixin Sun
Lixin Sun
JYJian Yao
Jian Yao
PHPan Hao
Pan Hao
YYYuanyuan Yang
Yuanyuan Yang
ZLZhimou Liu
Zhimou Liu
RPRuchen Peng
Ruchen Peng
We sought to systematically evaluate diagnostic performance of four-dimensional computed tomography (4D-CT) in the localization of hyperfunctioning parathyroid glands (HPGs) in patients with primary hyperparathyroidism (pHPT). We calculated the pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratios (DOR) of 4D-CT on a per-lesion level, as well as pooled sensitivity and positive predictive value (PPV) on a per-patient level with 95% confidence intervals (CIs). Additionally, we plotted summary receiver operating characteristic (SROC) curves and evaluated the areas under the curves (AUC). A total of 16 studies were included in the analysis. Their pooled sensitivity, specificity, PLR, NLR, and DOR of 4D-CT on per-lesion level were 75% (95%CI: 66–82%), 85% (95%CI: 50–97%), 4.9 (95%CI: 1.1–21.3), 0.30 (95%CI: 0.19–0.45), and 17 (95%CI: 3–100), respectively, with an AUC of 81% (95%CI: 77–84%). We also observed heterogeneity in sensitivity (I2 = 79%) and specificity (I2 = 94.7%), and obtained a pooled sensitivity of 81% (95%CI: 70–90%) with heterogeneity of 81.9% (p < 0.001) and PPV of 91% (95%CI: 82–98%) with heterogeneity of 80.8% (p < 0.001), based on a per-patient level. Overall, 4D-CT showed moderate sensitivity and specificity for preoperative localization of HPG(s) in patients with pHPT. The diagnostic performance may improve with 4D-CT’s promotion to first-line use on a lesion-based level, further research is needed to confirm the results.

12 July 2025 in Neurological Sciences
Verified
Journal Article
Open access
PDF file
JZJiali Zhong
Jiali Zhong
XJXiaoshan Jing
Xiaoshan Jing
YLYing Liang
Ying Liang
PHPan Hao
Pan Hao
RPRuchen Peng
Ruchen Peng
RXRui qiang Xin
Rui qiang Xin
Background: Post-stroke cognitive impairment (PSCI) is a common and severe consequence of ischemic stroke (IS) that significantly affects patient outcomes. Transcranial direct current stimulation (tDCS) has shown promise in enhancing cognitive function in IS patients, but its underlying mechanisms are not fully understood. This study investigates the effects of tDCS on brain functional connectivity and network topology using resting-state functional magnetic resonance imaging (rs-fMRI). Methods: In this double-blind study, sixty-five IS patients with PSCI were randomly assigned to either the tDCS or control group. Rs-fMRI data were acquired before and after the intervention. We analyzed functional connectivity (FC) and graph theory-based topological properties. Cognitive performance was assessed using the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA). Results after: treatment, both groups showed improvements in MMSE and MoCA scores, with the tDCS group demonstrating significantly greater improvements (p < 0.05). In the tDCS group, FC significantly increased between four pairs of brain regions (p < 0.05, FDR-corrected). Additionally, Global Efficiency (E g ) significantly improved (p < 0.05, FDR-corrected), and this improvement positively correlated with enhancements in MMSE scores (r = 0.403, p = 0.037). Conclusion: These findings suggest that tDCS improves cognitive function in PSCI by altering brain network connectivity and topological organization, providing neuroimaging evidence to support its therapeutic mechanisms.

18 December 2024 in Discover Oncology
Verified
Journal Article
Open access
PDF file
PHPan Hao
Pan Hao
RXRui qiang Xin
Rui qiang Xin
YLYancui Li
Yancui Li
XNXu Na
Xu Na
XLXiaoyong Lv
Xiaoyong Lv
Background This research utilized the bibliometrics method to analyze the published literature related to prostate cancer (PCa) imaging. Furthermore, current knowledge and research hotspots of radiomics in PCa diagnosis and treatment were comprehensively reviewed, as well as progress and emerging trends in field were explored. Methods In this investigation, the relevant literature on radiomics, and PCa was retrieved from Web of Science Core Collection (WoSCC) databases from 2000 and 2024. Furthermore, a comprehensive bibliometric analysis was carried out using advanced tools like CiteSpace6.2, VOS viewer, and the 'bibliometrix' package of R software to visualize the annual distribution of publications across various aspects such as authors, countries, journals, institutions, and keywords. Results This analysis included 593 from 58 countries including China and the United States. Chinese Academy of Sciences and Frontiers in Oncology were the institutions and journals that publish the most relevant articles, -while Radiology journal had the greatest number of co-cited publications. Furthermore, 3,621 authors published on this topic, of which Madabhushi Anant and Stoyanova Radka had the highest contributions. Moreover, Lambin, P. had the most co-citations. In addition, the diagnostic characteristics of radiomics in PCa imaging and treatment strategies are the current research focal points. The establishment of multi-functional imaging techniques and independent factor models warrants future investigation. Conclusions In summary, this analysis revealed that the research on PCa imaging is developing vigorously, focusing on the diagnostic methods and intervention measures of imaging in PCa diagnosis and treatment. In the future, there is an urgent need for improved collaboration and communication among countries and institutions.

29 December 2024 in Journal of International Medical Research
Verified
Journal Article
Open access
PHPan Hao
Pan Hao
RXRui qiang Xin
Rui qiang Xin
RPRuchen Peng
Ruchen Peng
YLYancui Li
Yancui Li
XNXu Na
Xu Na
LSLixin Sun
Lixin Sun
Objective: We aimed to evaluate the diagnostic utility of 3.0-T magnetic resonance (MR) diffusion-weighted imaging (DWI)-derived apparent diffusion coefficient (ADC) values in conjunction with clinical indices for prostate cancer (PCa). Methods: A retrospective analysis was conducted on the clinical data of 181 patients with suspected PCa who underwent MR DWI prior to biopsy at LuHe Hospital, Beijing, between February 2022 and July 2023. Patients were placed into Malignancy and Benign groups according to the biopsy results. Univariate and multivariate analyses were performed on the ADC values and clinical indicators, and then a combination predictive model was developed. The model’s diagnostic accuracy was assessed using receiver operating characteristic (ROC) curve and decision curves analysis (DCA), and a nomogram was constructed for the assessment of individual risk. Results: The ADC value and the free prostate-specific antigen and total prostate-specific antigen (tPSA) levels were found to be independent predictors of PCa. tPSA showed the best diagnostic performance, with an area under the curve (AUC) of 0.914. However, the combined model had a higher diagnostic accuracy, with an AUC of 0.959. Conclusion: The combined model has superior predictive performance to other diagnostic methods and should help with the avoidance of unnecessary prostate biopsies.

23 November 2022 in Journal of Radiation Research
Verified
Journal Article
Open access
PDF file
PHPan Hao
Pan Hao
CZChunli Zhang
Chunli Zhang
HMHuan Ma
Huan Ma
RWRongfu Wang
Rongfu Wang
Radioimmunotherapy (RIT) has great potential in cancer therapy. However, its efficacy in numerous tumors is restricted due to myelotoxicity, thereby limiting the dose of radionuclide. To increase tumor radiosensitivity, we incorporated the recombinant lentivirus into the EJ cells (bladder cancer [BC] cells), and examined the combined anti-tumor effects of RIT with 131I-BDI-1(131I-monoclonal antibody against human BC-1) and gene therapy (GT). The recombinant lentivirus was constructed and packed. The animal xenograft model was built and when the tumor reached about 0.5 cm in diameter, the mice were randomly separated into four groups: (1) RIT + GT: the xenografts were continuously incorporated with the recombinant lentivirus for two days. And 7.4 MBq 131I-BDI-1 was IV-injected, and 10 mg prodrug 5-fluorocytosine (FC) was IV-injected for 7 days, (2) RIT: same dose of 131I-BDI-1 as the previous group mice, (3) GT: same as the first group, except no 131I-BDI-1, and (4) Untreated. Compute tumor volumes in all groups. After 28 days the mice were euthanized and the tumors were extracted and weighed, and the inhibition rate was computed. The RIT + GT mice, followed by the RIT mice, exhibited markedly slower tumor growth, compared to the control mice. The tumor size was comparable between the GT and control mice. The tumor inhibition rates after 28 days of incubation were 42.85 ± 0.23%, 27.92 ± 0.21% and 0.57 ± 0.11% for the four groups, respectively. In conclusion, RIT, combined with GT, suppressed tumor development more effectively than RIT or GT alone. This data highlights the potent additive effect of radioimmune and gene therapeutic interventions against cancer.

28 August 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
PHPan Hao
Pan Hao
TZTong Zhu
Tong Zhu
RXRui qiang Xin
Rui qiang Xin
XLXiaoyong Lv
Xiaoyong Lv
Objective: Patients with prostate-specific antigen (PSA) levels in the 4–10 ng/mL gray zone present a diagnostic challenge, as PSA alone cannot reliably distinguish clinically significant prostate cancer (csPCa) from benign conditions or indolent disease, potentially leading to unnecessary biopsies or missed clinically significant disease. This study aimed to develop a risk prediction model for csPCa in this population using clinical indicators and magnetic resonance imaging (MRI) quantitative data, and to evaluate its potential value for risk stratification and as a supplementary tool for biopsy decision-making. Methods: We retrospectively included 210 patients with PSA levels in the 4–10 ng/mL range and confirmed pathological diagnoses, who were admitted to our hospital between January 2018 and June 2025. csPCa was defined as a Gleason score ≥ 7. Patients were stratified by pathological diagnosis (csPCa vs. non-csPCa) and randomly divided into training and internal validation sets in a 7:3 ratio. The following variables were collected for analysis: age, PSA, apparent diffusion coefficient (ADC), and relative T2 value. Univariate and multivariate logistic regression were used to identify independent predictors of csPCa. We constructed a prediction model and nomogram. The discriminating ability, calibration, and stability of the model were assessed using receiver operating characteristic (ROC) curves, calibration curves, and Bootstrap internal validation. Decision curve analysis (DCA) was performed to evaluate the model’s net benefit across clinically relevant threshold probabilities. Risk stratification was performed based on predicted probabilities. Results: Of the 210 patients, 50 had csPCa and 160 had non-csPCa lesions. Univariate regression showed associations between age, ADC value, and relative T2 value. Multivariate logistic regression identified age and relative T2 value as independent predictors in the final model. Internal validation using 1000 Bootstrap resampling with optimism correction yielded a corrected AUC of 0.698 (95% CI: 0.669–0.716), with a mean optimism of only 0.016, indicating minimal overfitting. The area under the curve (AUC) of the model was 0.720 in the training set and 0.711 in the validation set. The calibration curve for the training set demonstrated good agreement between predicted and observed probabilities. DCA showed net benefits across certain threshold probabilities. Risk stratification based on predicted probability showed csPCa detection rates of 14.7%, 28.3%, and 47.4% in low-, intermediate- and high-risk groups, respectively. Conclusions: The logistic binary classification model based on age and relative T2 value may assist in risk assessment for csPCa in PSA gray zone patients. However, its moderate discrimination suggests it should be used as a supplementary tool rather than a standalone diagnostic test. Risk stratification based on predicted probability may help identify different csPCa risk populations, but given the exploratory nature of this single-center retrospective study, multi-center, large-sample, and prospective studies are required for external validation and optimization before clinical implementation.